Biotechnology startup

InterValve

InterValve develops medical devices and technology for the catheter-based treatment of calcified aortic valve stenosis.

Funding reportedLast round: Debt financing

Biotechnology

What company datasets say InterValve raised

Funding, as reported

Reported in all14.1Min the source's currency
Rounds4
Last roundDebt financing
Last round dateJan 2015
Investors listed1

Biotechnology in the same market

Startups like it

Is this your company?

Add your raise, your deck and your story, and put InterValve in front of investors. Or tell us what we have wrong.